Life Sciences

Exclusively oriented towards venture capital, with investments made at various stages of maturity: from start-ups to companies having already reached a certain stage of their development,

Geographic coverage that includes France and the rest of Europe, but also the United States;

An approach focused on biotechnologies and, in particular:
- New markets in chemistry and developments in organic therapeutics,
- Innovative diagnostic tools and biomaterial engineering applications,
- Pharmaceutical packaging and formulation,
- “Cleantech” linked to biotechnologies.

The intention to support portfolio companies over the long term, while maintaining a diversified range of investments: the initial investment in each company is generally around €1-2 million, rising to at most €10 million following subsequent financing rounds.

Ipsogen – This “cancer profiler” develops and markets diagnostic tests for blood and breast cancers (www.ipsogen.com)

GenomeQuest – Develops and markets genome sequence data management software (www.genomequest.com)

Force A – Develops optical sensors to facilitate improvements in agricultural yields and assist with real-time crop management and the control of chemical entrants (www.force-a.eu)